Diabetic Perspectives

Death Pathways in T Cell Homeostasis and Their Role in Autoimmune Diabetes

Matthew A. Gronski¹, ²

Keywords: type 1 diabetes, T cell, apoptosis, programmed cell death, mitochondria, death receptor, fas

Abstract

T cell apoptosis is a process necessary for central and peripheral tolerance. It ensures the proper removal of autoreactive T cells during thymic development as well as T cell homeostasis and the downregulation of immune responses against antigens in the periphery. Thus it is essential for the prevention of autoimmunity. Apoptotic pathways can be triggered by intrinsic (mitochondria-based) and extrinsic (receptor-based) stimuli. Both pathways involve a cascade of proteolytic enzymes called caspases whose activation commits the cell to death. In the periphery, autoreactive lymphocytes can be silenced by developmental arrest (anergy), or deleted by programmed cell death (apoptosis) through receptor-based activation-induced cell death (AICD). Central tolerance seems to rely more heavily on the mitochondria-based, T cell receptor (TCR)-stimulated apoptotic pathway, since thymocytes lacking the pro-apoptotic Bcl-2 family member Bim are resistant to TCR-induced apoptosis. Furthermore, defects in the intrinsic pathway of apoptosis may impair clonal deletion of autoreactive T cells. Several animal models exist in which impaired apoptosis results in autoimmunity. Here, we discuss data that suggest defects in T cell apoptosis in type 1 diabetes mellitus.

Fulltext: HTML , PDF (292KB)

This article has been cited by other articles:

	Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation de Oliveira GL, Malmegrim KC, Ferreira AF, Tognon R, Kashima S, Couri CE, Covas DT, Voltarelli JC, de Castro FA Clin Exp Immunol 2012. 168(3):291-302
	T-cell death following immune activation is mediated by mitochondria-localized SARM Panneerselvam P, Singh LP, Selvarajan V, Chng WJ, Ng SB, Tan NS, Ho B, Chen J, Ding JL Cell Death Differ 2012. Epub
	Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes Han D, Leyva CA, Matheson D, Mineo D, Messinger S, Blomberg BB, Hernandez A, Meneghini LF, Allende G, Skyler JS, Alejandro R, Pugliese A, Kenyon NS Clin Immunol 2011. 139(3):290-301
	Autoimmune thyroiditis, pernicious anaemia, vitiligo and scleroatrophic lichen in a boy with short-chain AcylCoA dehydrogenase deficiency Stagi S, Gasperini S, Manoni C, Greco A, Funghini S, Donati A Horm Res Paediatr 2010. 73(5):409-413
	Gene therapy in diabetes Wong MS, Hawthorne WJ, Manolios N Self Nonself 2010. 1(3):165-175
	Mitochondrial DNA variants in the pathogenesis of type 2 diabetes - relevance of asian population studies Wang PW, Lin TK, Weng SW, Liou CW Rev Diabet Stud 2009. 6(4):237-246
	Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats Hao J, Shen W, Tian C, Liu Z, Ren J, Luo C, Long J, Sharman E, Liu J J Cell Mol Med 2008. Epub ahead of print
	BimEL-dependent apoptosis induced in peripheral blood lymphocytes with n-butyric acid is moderated by variation in expression of c-myc and p21(WAF1) Kalousek I, Brodska B, Otevrelova P, Röselova P Cell Biochem Funct 2008. 26(4):509-521
	Molecular mechanisms of autoimmunity Atassi MZ, Casali P Autoimmunity 2008. 41(2):123-132
	The Cross-Regulatory Relationship Between Human Dendritic and Regulatory T Cells and its Role in Type 1 Diabetes Mellitus Chang HW, Chow YH, Chong P, Sia C Rev Diabet Stud 2007. 4(2):68-76